Michael Gelband’s Global Cord Blood Corporation CO Stock Holding History

Michael Gelband’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,283	Closed	-$33K	–	2160
2020 Q1	$33K	Buy	+10,283	New	+$45K	﹤0.01%	988

Other funds holding CO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Michael Gelband's CO Position: Q2 2020 in Review

Michael Gelband sold out of Global Cord Blood Corporation (CO) in Q2 2020, closing a stake of 10,283 shares — an estimated $33K sold.

Michael Gelband first reported a position in CO in Q1 2020 and held it in 1 quarter. The position peaked at $33K in Q1 2020. 32 funds tracked by Wall St. Rank hold CO as of Q2 2020.

Michael Gelband reported no remaining Global Cord Blood Corporation position as of Q2 2020 after selling out during the quarter.
Michael Gelband sold 10,283 Global Cord Blood Corporation shares in Q2 2020, an estimated $33K.
Michael Gelband first reported a position in Global Cord Blood Corporation in Q1 2020 and held it in 1 quarter.
Michael Gelband's Global Cord Blood Corporation position peaked at $33K in Q1 2020.
32 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.